A common bacterial pathogen called Pseudomonas aeruginosa produces a virus that substantially increases the pathogen's ability to infect us, according to a study by investigators at the Stanford University School of Medicine.
Mar 28, 2019
0
1291
A team of researchers from the University of Iowa, University Medical Center Utrecht and Vertex Pharmaceuticals Incorporated, reports that earlier administration of a drug already given to patients with a rare form of cystic ...
An approved drug normally used to treat fungal infections could also do the job of a protein channel that is missing in the lungs of people with cystic fibrosis, operating as a prosthesis on the molecular scale, says new ...
Mar 13, 2019
0
2777
A new study, recently published in Nature Communications, has looked at infections in Danish youth with cystic fibrosis (CF) over a period of 10 years. This is the largest longitudinal study to date of the evolution involving ...
Mar 5, 2019
0
12
Bacteria lodged deep in Ella Balasa's lungs were impervious to most antibiotics. At 26, gasping for breath, she sought out a dramatic experiment—deliberately inhaling a virus culled from sewage to attack her superbug.
Feb 26, 2019
0
1
Dangerous to both mom and baby, infections or inflammations of the tissue or fluids that surround the fetus often result in preterm delivery with a high risk of serious complications for the infant. A prescription drug used ...
Feb 18, 2019
0
6
The American Thoracic Society has developed a new clinical practice guideline for home oxygen therapy for children. The guideline appears in the Feb. 1 edition of the Society's American Journal of Respiratory and Critical ...
Feb 1, 2019
0
1
Flu vaccination is provided free for children with chronic illnesses, yet uptake is low prompting UNSW researchers to call for renewed efforts to get this message out to parents in order to keep affected children out of hospital.
Feb 1, 2019
0
0
Researchers exploring the effects of a long-standing treatment for cystic fibrosis have discovered a potential new target for drugs to treat the disease, which has no cure and typically cuts decades off the lives of patients.
Jan 31, 2019
0
25
An open label Phase 3 study conducted at Ann & Robert H. Lurie Children's Hospital of Chicago and other centers established that a combination of cystic fibrosis drugs lumacaftor and ivacaftor is safe and effective in children ...
Jan 25, 2019
0
1
